このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Charles River Laboratories International マネジメント
マネジメント 基準チェック /44
Charles River Laboratories International'sの CEO はJim Fosterで、 Jan1991年に任命され、 の在任期間は 33.42年です。 の年間総報酬は$ 14.10Mで、 10.4%給与と89.6%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.51%を直接所有しており、その価値は$ 55.01M 。経営陣と取締役会の平均在任期間はそれぞれ4.6年と6.9年です。
主要情報
Jim Foster
最高経営責任者
US$14.1m
報酬総額
| CEO給与比率 | 10.4% |
| CEO在任期間 | 33.4yrs |
| CEOの所有権 | 0.5% |
| 経営陣の平均在職期間 | 4.6yrs |
| 取締役会の平均在任期間 | 6.9yrs |
経営陣の近況
Recent updates
Charles River Laboratories: Fair Valuation Against Fundamentals
May 31What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
May 25
Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?
Apr 27Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings
Apr 11Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues
Feb 21Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'
Feb 16Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?
Jan 17Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up
Jan 02Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth
Dec 17Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation
Nov 26Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 29% Discount?
Nov 12Charles River: Q3 Points To Ongoing Deterioration
Nov 09Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 27At US$197, Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth Looking At Closely?
Oct 12Charles River Laboratories: Diving Into The Lab (Rating Upgrade)
Oct 06Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 27% Discount?
Aug 10Charles River Laboratories: Very Attractive After The Pullback
Jul 26Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?
Jul 22Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly
Jul 03When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?
Jun 19A Look At The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)
May 01Should You Be Adding Charles River Laboratories International (NYSE:CRL) To Your Watchlist Today?
Apr 16These 4 Measures Indicate That Charles River Laboratories International (NYSE:CRL) Is Using Debt Reasonably Well
Apr 02Is Charles River Laboratories International, Inc. (NYSE:CRL) Potentially Undervalued?
Mar 19Charles River gains as Guggenheim upgrades despite post-earnings selloff
Feb 23Charles River Laboratories International: A Great Business At A Decent Price
Feb 06Charles River acquires SAMDI Tech for $50M in cash
Jan 30Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth US$253 Based On Its Intrinsic Value?
Jan 24If EPS Growth Is Important To You, Charles River Laboratories International (NYSE:CRL) Presents An Opportunity
Jan 10Charles River Laboratories sells Avian Vaccine Services business to Arlington Capital
Jan 05We Think Charles River Laboratories International (NYSE:CRL) Can Stay On Top Of Its Debt
Dec 28Is Charles River Laboratories International, Inc. (NYSE:CRL) Potentially Undervalued?
Dec 14CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 30 2024 | n/a | n/a | US$444m |
| Dec 30 2023 | n/a | n/a | US$475m |
| Sep 30 2023 | n/a | n/a | US$475m |
| Jul 01 2023 | n/a | n/a | US$484m |
| Apr 01 2023 | n/a | n/a | US$496m |
| Dec 31 2022 | US$13m | US$1m | US$486m |
| Sep 24 2022 | n/a | n/a | US$436m |
| Jun 25 2022 | n/a | n/a | US$443m |
| Mar 26 2022 | n/a | n/a | US$422m |
| Dec 25 2021 | US$14m | US$1m | US$391m |
| Sep 25 2021 | n/a | n/a | US$397m |
| Jun 26 2021 | n/a | n/a | US$396m |
| Mar 27 2021 | n/a | n/a | US$375m |
| Dec 26 2020 | US$13m | US$1m | US$364m |
| Sep 26 2020 | n/a | n/a | US$301m |
| Jun 27 2020 | n/a | n/a | US$271m |
| Mar 28 2020 | n/a | n/a | US$248m |
| Dec 28 2019 | US$18m | US$1m | US$252m |
| Sep 28 2019 | n/a | n/a | US$231m |
| Jun 29 2019 | n/a | n/a | US$219m |
| Mar 30 2019 | n/a | n/a | US$227m |
| Dec 29 2018 | US$14m | US$1m | US$225m |
| Sep 29 2018 | n/a | n/a | US$135m |
| Jun 30 2018 | n/a | n/a | US$128m |
| Mar 31 2018 | n/a | n/a | US$129m |
| Dec 30 2017 | US$13m | US$1m | US$123m |
報酬と市場: Jimの 総報酬 ($USD 14.10M ) は、 US市場 ($USD 13.53M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Jimの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Jim Foster (73 yo)
33.4yrs
在職期間
US$14,096,923
報酬
Mr. James C. Foster, J.D. has been the Chairman of the Board at Charles River Laboratories, Inc. (CRL) since 2000 and has been its Chief Executive Officer since 1992 and serves as its President since 1991....
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Chairman | 33.4yrs | US$14.10m | 0.51% $ 54.5m | |
| Corporate Executive VP & CFO | 2.1yrs | US$3.81m | 0.0049% $ 522.0k | |
| Corporate Executive VP & COO | 2.6yrs | US$4.99m | 0.082% $ 8.7m | |
| Corporate Executive Vice President of Corporate Development & Strategy | 13.4yrs | US$3.06m | 0.025% $ 2.6m | |
| Corporate Executive Vice President of Community Relations | 7.7yrs | US$2.91m | 0.051% $ 5.4m | |
| Corporate Senior VP & Chief Accounting Officer | 7.2yrs | データなし | 0.010% $ 1.1m | |
| Corporate Senior VP & Chief Scientific Officer | 2.6yrs | データなし | データなし | |
| Corporate Senior VP & Chief Information Officer | 3yrs | データなし | データなし | |
| Corporate Vice President of Investor Relations | no data | データなし | データなし | |
| Corporate Senior VP | 3.8yrs | データなし | データなし | |
| Corporate Vice President & Chief Communications Officer | no data | データなし | データなし | |
| Corporate Executive VP & Chief People Officer | 5.4yrs | データなし | 0.020% $ 2.1m |
4.6yrs
平均在職期間
54yo
平均年齢
経験豊富な経営陣: CRLの経営陣は 経験豊富 であると考えられます ( 4.6年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Chairman | 35.4yrs | US$14.10m | 0.51% $ 54.5m | |
| Independent Director | 13.4yrs | US$339.77k | 0.046% $ 4.9m | |
| Lead Independent Director | 21.4yrs | US$371.02k | 0.010% $ 1.1m | |
| Independent Director | 4.7yrs | US$346.02k | 0.0066% $ 702.7k | |
| Independent Director | 13.4yrs | US$346.02k | 0.062% $ 6.6m | |
| Independent Director | 1.5yrs | US$437.78k | 0.0018% $ 187.1k | |
| Director | 6.9yrs | US$336.02k | 0.023% $ 2.4m | |
| Independent Director | 15.7yrs | US$339.77k | 0.014% $ 1.5m | |
| Independent Director | 4.3yrs | US$339.77k | 0.0048% $ 507.1k | |
| Independent Director | 3.7yrs | US$324.77k | 0.0048% $ 512.4k | |
| Independent Director | less than a year | データなし | 0.00033% $ 35.1k |
6.9yrs
平均在職期間
68yo
平均年齢
経験豊富なボード: CRLの 取締役会 は 経験豊富 であると考えられます ( 6.9年の平均在任期間)。